An Act to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes.
Citations are generated automatically from bibliographic data
as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. Senate. Food and Drug Administration Safety and Innovation Act. S. 3187. 112th
Cong., 2nd
sess., Engrossed Amendment House June 20, 2012. https://www.govinfo.gov/app/details/BILLS-112s3187eah.
APA
Congress, House of Representatives (2012, June 20). Food and Drug Administration Safety and Innovation Act (S. 3187 (EAH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-112s3187eah.
MLA
United States, Congress, House of Representatives. Food and Drug Administration Safety and Innovation Act. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-112s3187eah. 112th Congress, S. 3187, Engrossed Amendment House 20 Jun. 2012.
Bluebook
S.3187 - 112th Congress (2011-2012): Food and Drug Administration Safety and Innovation Act, S.3187, 112th Cong. (2012), https://www.govinfo.gov/app/details/BILLS-112s3187eah.
